Lily James showcases her jaw-dropping figure in a bikini as she shares holiday album and a very cheeky inspirational message
The actress, 35, looked laid back as she sat down for dinner during the winter escape, covering her mouth with her phone.
Ozempic ‘microdosing’ is gaining popularity — but is it effective?
A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic.
WDHN4d
West Virginia patients are left in limbo over changing insurance coverage of obesity medications
Lory Osborn says the Wegovy she was prescribed 15 months ago did more than help her lose 75 pounds — over a quarter of her ...
Today7d
Is Ozempic safe for weight loss? What doctors want you to know
Ozempic is synonymous with weight loss for many people, even as they can turn to drugs with other brand names that have been tailored to treat obesity. The blockbuster Type 2 diabetes medication ...
MarketWatch10d
Mondelez is reportedly exploring a Hershey acquisition. Drugs like Ozempic could justify a deal.
Drugs like Ozempic could justify a deal. Hershey ‘now faces long-term headwinds from the expansion of GLP-1 drugs and heightened scrutiny on unhealthy food in the U.S.,’ TD Cowen says ...
Today13d
Foods to avoid if you are taking Ozempic or Wegovy for weight loss
People who use Ozempic or Wegovy for weight loss often find they must avoid certain foods to minimize side effects from the medications. Both drugs contain semaglutide, a synthetic version of a ...
NBC Los Angeles14d
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions – NBC Los Angeles
The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next two to three months.
Mint14d
Weight-loss drugs: A game changer for India’s top pharma companies
Simultaneously, the market for weight-loss drugs is experiencing a revolutionary shift, driven by advances in treatments like Ozempic, Wegovy, and Zepbound—three drugs that are showing ...
Nasdaq14d
Here's Why Penumbra (PEN) is a Strong Growth Stock
For new and old investors, taking full advantage of the stock market and investing with ... in markets with significant unmet needs. PEN is a #2 (Buy) on the Zacks Rank, with a VGM Score of ...
CNN17d
An experimental drug drove people to lose 23% of their body weight. It’s still seen as a disappointment
Since Ozempic blasted onto the stage in 2017 with ... additional weight loss potential of CagriSema.” Novo Nordisk’s stock fell about 19% in early Friday trading on the news, wiping out ...
Business Insider17d
Novo Nordisk stock plunges 20% after a trial of its latest weight loss drug disappoints
Novo Nordisk's stock suffered its biggest one-day slide on record after its latest obesity drug trial disappointed investors hoping for another blockbuster weight-loss drug. The Ozempic-maker's ...
MarketWatch18d
Ozempic parent’s stock having worst day since the 1980s as new weight-loss drug disappoints
That news was welcome to rival Eli Lilly and Co., which makes weight-loss drugs Zepbound and Mounjaro that compete with Novo Nordisk’s Wegovy and Ozempic. Tomi Kilgore is MarketWatch's deputy ...